| # | Side effect | Count |
|---|---|---|
| 0 | DRUG INEFFECTIVE | 1645 |
| 1 | OFF LABEL USE | 1253 |
| 2 | DRUG INTERACTION | 1133 |
| 3 | DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS | 765 |
| 4 | NAUSEA | 698 |
| 5 | CONDITION AGGRAVATED | 634 |
| 6 | PRODUCT USE IN UNAPPROVED INDICATION | 605 |
| 7 | PYREXIA | 592 |
| 8 | VOMITING | 497 |
| 9 | DRUG RESISTANCE | 474 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | TYPE 2 LEPRA REACTION | 61 | 0.3262 |
| 1 | IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS | 100 | 0.2985 |
| 2 | MYCOBACTERIUM ULCERANS INFECTION | 16 | 0.2807 |
| 3 | CYSTIC FIBROSIS PANCREATIC | 9 | 0.2000 |
| 4 | TYPE 1 LEPRA REACTION | 10 | 0.1961 |
| 5 | ATYPICAL MYCOBACTERIUM TEST POSITIVE | 18 | 0.1856 |
| 6 | TUBERCULOMA OF CENTRAL NERVOUS SYSTEM | 32 | 0.1758 |
| 7 | ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION | 12 | 0.1667 |
| 8 | ANTICOAGULATION DRUG LEVEL DECREASED | 17 | 0.1405 |
| 9 | TUBERCULOSIS OF EYE | 9 | 0.1286 |